Cargando…

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer

PURPOSE: This study investigated the clinical impact of pretreatment neutrophil-to-lymphocyte ratio (NLR) on survival in patients with oligometastatic breast cancer. PATIENTS AND METHODS: We collected data from 397 patients who underwent primary breast surgery from 2004 to 2015 and developed recurre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Yuka, Fujishima, Makoto, Ono, Makiko, Masuda, Jun, Ozaki, Yukinori, Maeda, Tetsuyo, Uehiro, Natsue, Takahashi, Yoko, Kobayashi, Takayuki, Sakai, Takehiko, Osako, Tomo, Ueno, Takayuki, Ohno, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581831/ https://www.ncbi.nlm.nih.gov/pubmed/36153381 http://dx.doi.org/10.1007/s10549-022-06726-w

Ejemplares similares

Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center
por: Ozaki, Yukinori, et al.
Publicado: (2021)

Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility
por: Kumegawa, Kohei, et al.
Publicado: (2023)

Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility
por: Kumegawa, Kohei, et al.
Publicado: (2023)

Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
por: Maeshima, Yurina, et al.
Publicado: (2021)

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer
por: Inagaki, Lina, et al.
Publicado: (2021)

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study
por: Ozaki, Yukinori, et al.
Publicado: (2022)

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer
por: Kumegawa, Kohei, et al.
Publicado: (2022)

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
por: Ishiguro, Hiroshi, et al.
Publicado: (2020)

Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report
por: Maeshima, Yurina, et al.
Publicado: (2021)

A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer
por: Takada, Masahiro, et al.
Publicado: (2023)

Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin
por: Saeki, Sumito, et al.
Publicado: (2023)

Efficacy of radiation boost after breast-conserving surgery for breast cancer with focally positive, tumor-exposed margins
por: Suzuki, Ryoko, et al.
Publicado: (2020)

Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
por: Watanabe, Kenichi, et al.
Publicado: (2023)

Assessment of a cancer genomic profile test for patients with metastatic breast cancer
por: Fukada, Ippei, et al.
Publicado: (2022)

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study
por: Ozaki, Yukinori, et al.
Publicado: (2022)

The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor‐positive breast cancer
por: Fukuoka, Megumi, et al.
Publicado: (2022)

Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
por: Masuda, Norikazu, et al.
Publicado: (2021)

Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment
por: Miyata, Kenichi, et al.
Publicado: (2023)

Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study
por: Poulsen, Mads Hvid, et al.
Publicado: (2019)

Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
por: Chen, Yi-Xing, et al.
Publicado: (2023)

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
por: Masuda, Norikazu, et al.
Publicado: (2020)

A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer
por: Iwata, Hiroji, et al.
Publicado: (2013)

Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
por: Iwata, Hiroji, et al.
Publicado: (2023)

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial
por: Nomura, Takashi, et al.
Publicado: (2021)

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)
por: Ohno, Shinji, et al.
Publicado: (2020)

Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
por: Iwamoto, Takayuki, et al.
Publicado: (2016)

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
por: Deek, Matthew P., et al.
Publicado: (2022)

The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI study
por: Takahashi, Masato, et al.
Publicado: (2020)

A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients
por: Osako, Tomo, et al.
Publicado: (2017)

A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
por: Fukada, Ippei, et al.
Publicado: (2021)

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
por: Ohno, S., et al.
Publicado: (2013)

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
por: Iwata, Hiroji, et al.
Publicado: (2018)

Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence
por: Sato, Ayaka, et al.
Publicado: (2019)

Intratumoral heterogeneity, treatment response, and survival outcome of ER‐positive HER2‐positive breast cancer
por: Teruya, Natsuki, et al.
Publicado: (2023)

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
por: Sasada, Shinsuke, et al.
Publicado: (2023)

Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
por: Uehiro, Natsue, et al.
Publicado: (2016)

Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes
por: Iizuka, Misato, et al.
Publicado: (2015)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Imaging of Oligometastatic Disease
por: Vietti Violi, Naik, et al.
Publicado: (2022)

Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial
por: Tsujita, Makoto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r4cvao1mipgu45bjvti61nmre3